cover of episode History of Nerve-Sparing Prostate Cancer Surgery with Herbert Lepor, MD

History of Nerve-Sparing Prostate Cancer Surgery with Herbert Lepor, MD

2023/9/5
logo of podcast The Dr. Geo Podcast

The Dr. Geo Podcast

Frequently requested episodes will be transcribed first

Shownotes Transcript

Dr. Geo converses with Dr. Herb Lepor, the esteemed Chairman of Urology at NYU Langone Health. (Quick note: He's also Dr. Geo's boss, so expect some fun dynamics!) Dr. Lepor's deep involvement in this field, particularly alongside Dr. Patrick Walsh, makes him an authority. Together, they delve into their co-authored research on the nerve-sparing technique, tracing its origin and understanding its significance in today's medical paradigm.

In this episode, they explore:

  • The latest breakthroughs in prostate cancer treatments.

  • A comparative discussion on open versus robotic prostatectomy.

  • A deep dive into focal therapies and where prostate cancer treatments are headed.

But there's more to medicine than just procedures and techniques. Dr. Lepore is approaching a rare milestone: 30 years as the chair of a medical department. What does leading with consistency and vision take in an ever-evolving domain like urology? Dr. Lepore shares his insights, challenges, and the human side of his extraordinary journey.

Join Dr. Geo as he engages with Dr. Herb Lepore, exploring the advancements in prostate cancer care and the stories behind a stellar leadership legacy.


Thank you to our sponsors.

This episode is brought to you by ExoDx™ Prostate Test) for prostate tissue. The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in the “gray zone” who may be considering a biopsy. The ExoDx Prostate test provides a risk score that determines a patient’s potential risk of clinically significant prostate cancer (Gleason Score ≥7). The test is included in the National Comprehensive Cancer Network (NCCN) guidelines and has been clinically validated at the cut-point of 15.6 with a 91% sensitivity and 92% negative predictive value, meaning there is less than a 9% chance of having aggressive prostate cancer below the validated cut-point of 15.6. Ask your urologist about the ExoDx Prostate Test.)

This episode is also brought to you by AG1 (Athletic Greens)). AG1 contain 75 high-quality vitamins, minerals, whole-food sourced ingredients, probiotics, and adaptogens to help you start your day right. This special blend of ingredients supports your gut health, your nervous system, your immune system, your energy, recovery, focus, and aging. All the things. Enjoy AG1 (Athletic Greens)).


Thanks for listening to this week's episode. Subscribe to The Dr. Geo YouTube Channel) to get more content like this and learn how you can live better with age.

You can also listen to this episode and future episodes of the Dr. Geo Podcast by clicking HERE).


Follow Dr. Geo on social media. Facebook), Instagram) Click here) to become a member of Dr. Geo’s Health Community.

Improve your urological health with Dr. Geo’s formulated supplement lines: XY Wellness) for Prostate cancer lifestyle and nutrition: Mr. Happy) Nutraceutical Supplements for prostate health and male optimal living.

You can also check out Dr. Geo’s online dispensary for other supplement recommendations Dr. Geo’s Supplement Store)


DISCLAIMER: This audio is educational and does not constitute medical advice. This audio's content is my opinion and not that of my employer(s) or any affiliated company.

Use of this information is at your own risk. Geovanni Espinosa, N.D., will not assume any liability for any direct or indirect losses or damages that may result from the use of the information contained in this video, including but not limited to economic loss, injury, illness, or death.